Scarica l'app Stockscreener
14.80
21.11%
2.58
Dopo l'orario di chiusura:
13.60
-1.20
-8.11%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché RNAZ Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.22
Aprire:
$18.71
Volume 24 ore:
7.49M
Relative Volume:
52.96
Capitalizzazione di mercato:
$12.34M
Reddito:
-
Utile/perdita netta:
$-14.93M
Rapporto P/E:
-0.0556
EPS:
-266.137
Flusso di cassa netto:
$-15.87M
1 W Prestazione:
+39.49%
1M Prestazione:
+36.28%
6M Prestazione:
+36.23%
1 anno Prestazione:
-96.68%
Intervallo 1D:
$13.18
$20.99
Intervallo di 1 settimana:
$10.32
$20.99
Portata 52W:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Nome
Transcode Therapeutics Inc
Settore
Industria
Telefono
857-301-6857
Indirizzo
6 LIBERTY SQUARE, BOSTON
Confronta RNAZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
14.80 | 10.19M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Transcode Therapeutics Inc Borsa (RNAZ) Ultime notizie
TransCode Therapeutics, Inc. (RNAZ) Stock :Soars as $25M Investment and Polynoma Acquisition Ignite Growth Prospects - parameter.io
TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences - citybiz
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout - Benzinga
Transcode announces the acquisition of Polynoma and a $25 mln financing by subsidiary of CK Life Sciences - MarketScreener
TransCode Therapeutics stock soars after Polynoma acquisition By Investing.com - Investing.com Canada
TransCode Acquires Polynoma, Secures $25M Strategic Investment | RNAZ Stock News - Stock Titan
TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Stocktwits
Chart based exit strategy for TransCode Therapeutics Inc.2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Strategies to average down on TransCode Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
TransCode Therapeutics Amends Patent License Agreement - TipRanks
TransCode Therapeutics (NASDAQ:RNAZ) Trading Down 1.5% – What’s Next? - Defense World
Will TransCode Therapeutics Inc. stock go up soonMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Is TransCode Therapeutics Inc. stock bottoming outJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com
TransCode Therapeutics Passes Key Proposals at Annual Meeting - MSN
How hedge fund analytics apply to TransCode Therapeutics Inc. stock2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Developing predictive dashboards with TransCode Therapeutics Inc. dataMarket Sentiment Review & Safe Capital Allocation Plans - newser.com
TransCode Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Our Picks = Your Future Gains - earlytimes.in
What analysts say about TransCode Therapeutics Inc stockShort-Term Trading Alerts & Build a Smarter Portfolio Right Now - earlytimes.in
A activity2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
What to expect from CPSH in the next 30 daysWatch List & High Accuracy Swing Entry Alerts - newser.com
Is Mineralys Therapeutics Inc. stock poised for growthJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
NGVT stock trend outlook and recovery pathMarket Movement Recap & Safe Entry Momentum Tips - newser.com
How high can TransCode Therapeutics Inc. stock goCPI Data & Safe Capital Growth Tips - newser.com
Published on: 2025-09-21 07:32:21 - خودرو بانک
Macro Review: Why is TransCode Therapeutics Inc stock going downWeekly Profit Report & Real-Time Volume Analysis - khodrobank.com
Loss Report: Is TransCode Therapeutics Inc subject to activist investor interest2025 Geopolitical Influence & High Conviction Trade Alerts - خودرو بانک
Applying Wyckoff theory to TransCode Therapeutics Inc. stockFed Meeting & Risk Managed Investment Entry Signals - newser.com
Earnings Miss: What makes TransCode Therapeutics Inc stock attractive today2025 Market Overview & Community Trade Idea Sharing - khodrobank.com
Market Overview: What are analysts price targets for TransCode Therapeutics Inc2025 Buyback Activity & Risk Controlled Swing Alerts - khodrobank.com
Growth Review: Is TransCode Therapeutics Inc undervalued by DCF analysis2025 Bull vs Bear & Verified Chart Pattern Trade Signals - خودرو بانک
Transcode Therapeutics Inc Azioni (RNAZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
4.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):